You are not logged in.

Stenting as first-line management for all patients with nonperforating left-sided obstructing colorectal cancer

Warden, C., Stupart, Douglas and Goldberg, P. 2013, Stenting as first-line management for all patients with nonperforating left-sided obstructing colorectal cancer, Colorectal disease, vol. 15, no. 7, pp. e389-e395, doi: 10.1111/codi.12206.

Attached Files
Name Description MIMEType Size Downloads

Title Stenting as first-line management for all patients with nonperforating left-sided obstructing colorectal cancer
Author(s) Warden, C.
Stupart, Douglas
Goldberg, P.
Journal name Colorectal disease
Volume number 15
Issue number 7
Start page e389
End page e395
Total pages 7
Publisher Wiley
Place of publication Chichester, Eng.
Publication date 2013-07
ISSN 1462-8910
1463-1318
Keyword(s) colonic stents
bowel obstruction
colorectal cancer
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Cohort Studies
Colonoscopy
Colorectal Neoplasms
Decompression, Surgical
Female
Humans
Intestinal Obstruction
Male
Middle Aged
Palliative Care
Prospective Studies
Stents
Treatment Outcome
Science & Technology
Life Sciences & Biomedicine
Gastroenterology & Hepatology
Surgery
EMERGENCY-SURGERY
COLON-CANCER
TRIAL
MORBIDITY
Summary AIM: Since 2005, we have used self-expanding metal stents (SEMS) as primary treatment for all patients with left-sided obstructing colorectal cancer without evidence of perforation. The purpose of this study was to assess the safety and efficacy of this treatment.

METHOD: This was a prospective study of consecutive patients with left-sided obstructing colorectal cancer without perforation or peritonitis treated between January 2005 and June 2009. SEMS placement was attempted in all cases. Emergency surgery was reserved for patients in whom a stent placement failed. After successful decompression, surgery was offered to patients with potentially curable disease.

RESULTS: Seventy-seven patients were included, with successful SEMS placement in 60/77 (78%) patients, 25 as a bridge to surgery and 35 for palliation. Immediate complications occurred in two (3%) cases. There was no mortality. Of 35 patients in whom SEMS was for palliation, 32 (91%) avoided surgery altogether. A stoma was fashioned in 5 (8.3%) of the 60 patients who were successfully stented, and in 12 (71%) of the 17 patients in whom stenting failed (P = 0.0001).

CONCLUSION: A SEMS-based management protocol for patients with large bowel obstruction due to colorectal cancer is safe and effective.
Language eng
DOI 10.1111/codi.12206
Field of Research 111299 Oncology and Carcinogenesis not elsewhere classified
1103 Clinical Sciences
Socio Economic Objective 920102 Cancer and Related Disorders
HERDC Research category C1.1 Refereed article in a scholarly journal
ERA Research output type C Journal article
Copyright notice ©2013, Association of Coloproctology of Great Britain and Ireland
Persistent URL http://hdl.handle.net/10536/DRO/DU:30088105

Document type: Journal Article
Collections: Faculty of Health
School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 3 times in TR Web of Science
Scopus Citation Count Cited 4 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 23 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 20 Oct 2016, 14:25:03 EST

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.